Avenova, PRN Vision Group, and EyePromise are now united—welcome to the new EyePromise experience.

DVS

Supplement for Improved Visual Function and Retinal Health

Science-supported nutrition to support vascular and eye health, without impacting blood glucose levels.

SIZE: 1 Month Supply
1 Month Supply
1 BOTTLE
$45.95
Select an option:
1
Clinical Partnership

Science Backed. Doctor Trusted. Patient Approved.

EyePromise formulas are built on decades of research and direct collaboration with industry-leading optometrists and ophthalmologists. Clinically backed, tested and shown to perform.

#1
Doctor Recommended Across Multiple Eye Health Segments
8,500
Eyecare professionals
20
Years of expertise
1.5m+
People supported by EyePromise

Reviews

The reviews and testimonials displayed on this website reflect the real‑life experiences and opinions of individual consumers. These reviews are voluntarily submitted and represent personal experiences only; they are not verified medical statements and may not reflect typical results. The statements made in customer reviews are not intended to diagnose, treat, cure, or prevent any disease, and should not be interpreted as health or disease claims about our products.

Our products are not intended to replace professional medical advice, diagnosis, or treatment. Always consult your healthcare provider regarding any health‑related questions or before beginning any new regimen.

Frequently Asked Questions

References

  1. Olk RJ, Peralta E, Gierhart DL, Brown GC, Brown MM. Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness analysis. Int J Retina Vitreous. 2015 Nov 9;1:22. doi: 10.1186/s40942-015-0019-2. PMID: 27847615; PMCID: PMC5088486.
  1. AREDS2 Research Group; Chew EY, Clemons T, SanGiovanni JP, Danis R, Domalpally A, McBee W, Sperduto R, Ferris FL. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology. 2012 Nov;119(11):2282-9. doi: 10.1016/j.ophtha.2012.05.027. Epub 2012 Jul 26. PMID: 22840421; PMCID: PMC3485447.